Viralytics Limited announced that it has received AUD 29.63 million in funding from Lepu Medical Technology Co., Ltd.
January 03, 2018
Share
Viralytics Limited (ASX:VLA) announced a private placement of 36,138,637 shares at a price of AUD 0.82 per share for gross proceeds of AUD 29,633,682 on January 4, 2018. The transaction included participation from the new investor Lepu Medical Technology (Beijing) Co., Ltd. (SZSE:300003). The investor has acquired 13.04% stake in the company. The transaction has been approved by the board of directors of the investor at its 7th meeting of its 4th Directorate and the 7th meeting of the 4th supervisory board.
Lepu Medical Technology (Beijing) Co., Ltd. specialized in the design, manufacture and marketing of medical devices and equipment. The group is also involved in the development and manufacturing of active pharmaceutical ingredients. Net sales break down by activity as follows:
- sale of medical devices and instruments (57.9%): primarily for cardiovascular interventions, cardiac surgery, cardiac rhythm management, anesthesia, intensive care, in vitro diagnostics and general surgery;
- sale of active pharmaceutical ingredients (30.6%): for the manufacturing of pharmaceutical products in the fields of cardiovascular diseases, infectious diseases, oncology, central nervous system disorders, etc.;
- sale of digital health and hospital network management solutions (11.6%).
China accounts for 64.7% of net sales.
LEPU MEDICAL TECHNOLOGY (BEIJING) CO., LTD. 
